title: Antiplatelet therapy after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk.
authors.forename: Justin
authors.initials: J
authors.lastname: Nowell
authors.forename: Marjan
authors.initials: M
authors.lastname: Jahangiri
mesh_terms: D001021:Aortic Valve / Q000601:surgery*; D001705:Bioprosthesis; D019317:Evidence-Based Medicine; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011182:Postoperative Care / Q000379:methods; D019564:Unnecessary Procedures
chemical_list: D010975:Platelet Aggregation Inhibitors